SQSTM1 and metabolic dysfunction-associated steatotic liver disease: Other authors have also observed a significant accumulation of p62/SQSTM1 protein in the livers of patients with MASLD compared to individuals with histologically normal livers, with a more pronounced increase in p62/SQSTM1 protein aggregation observed in MASH compared to simple steatosis [76, 77].